Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Nitric Oxide in Stroke-2 (ENOS-2/GTN feasibility)
2020-001304-42Phase 2Unknown
- Sponsor
- University of Nottingham
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in ischemic stroke, intracerebral hemorrhage (ICH) and stroke comparing Transiderm-Nitro 5 (nitroglycerin) with Sham patch (placebo) (2 arms). Primary endpoint: Primary feasibility endpoint. Status: unknown.
02
Drugs
nitroglycerin
03
Conditions
ischemic strokeintracerebral hemorrhage (ICH)stroke
Beyond the preview
Go deeper on 2020-001304-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001304-42.